Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Hancock

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|February 2, 2006
Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trialS Dixon, S J Walters, L Turner, et al.
International Journal of Oncology|July 11, 2001
The skeletal metastatic complications of renal cell carcinomaJ Zekri, N Ahmed, R E Coleman, et al.
Postgraduate Medical Journal|May 1, 1986
Protein losing enteropathy as a sole manifestation of non-Hodgkin's lymphomaA Konar, C B Brown, B W Hancock, et al.
International Journal of Oncology|May 11, 2006
Primary bone lymphoma: a retrospective analysisJ M Horsman, J Thomas, R Hough, et al.
Clinical Oncology|June 1, 1977
The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphomaB W Hancock, L Bruce, A M Ward, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1988
Transfer factor in Hodgkin's disease: a randomized clinical and immunological studyB W Hancock, L Bruce, R J Sokol, et al.
British Medical Journal|February 7, 1976
Changes in immune status in patients undergoing splenectomy for the staging of Hodgkin's diseaseB W Hancock, L Bruce, A M Ward, et al.
International Journal of Oncology|October 20, 2004
Primary B-cell lymphoma of the skin: the Sheffield Lymphoma Group Experience (1984-2003)L El-Helw, S Goodwin, D Slater, et al.
BMJ (Clinical Research Ed.)|January 4, 1997
Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's collaboration in British National Lymphoma Investigation studiesB W Hancock, M Aitken, C Radstone, et al.
Spine|January 1, 1992
Primary spinal presentation of non-Hodgkin's lymphoma. A reappraisal of management and prognosisR J Laing, J Jakubowski, I H Kunkler, et al.
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|February 2, 2006
Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trialS Dixon, S J Walters, L Turner, et al.
International Journal of Oncology|July 11, 2001
The skeletal metastatic complications of renal cell carcinomaJ Zekri, N Ahmed, R E Coleman, et al.
Postgraduate Medical Journal|May 1, 1986
Protein losing enteropathy as a sole manifestation of non-Hodgkin's lymphomaA Konar, C B Brown, B W Hancock, et al.
International Journal of Oncology|May 11, 2006
Primary bone lymphoma: a retrospective analysisJ M Horsman, J Thomas, R Hough, et al.
Clinical Oncology|June 1, 1977
The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphomaB W Hancock, L Bruce, A M Ward, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1988
Transfer factor in Hodgkin's disease: a randomized clinical and immunological studyB W Hancock, L Bruce, R J Sokol, et al.
British Medical Journal|February 7, 1976
Changes in immune status in patients undergoing splenectomy for the staging of Hodgkin's diseaseB W Hancock, L Bruce, A M Ward, et al.
International Journal of Oncology|October 20, 2004
Primary B-cell lymphoma of the skin: the Sheffield Lymphoma Group Experience (1984-2003)L El-Helw, S Goodwin, D Slater, et al.
BMJ (Clinical Research Ed.)|January 4, 1997
Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's collaboration in British National Lymphoma Investigation studiesB W Hancock, M Aitken, C Radstone, et al.
Spine|January 1, 1992
Primary spinal presentation of non-Hodgkin's lymphoma. A reappraisal of management and prognosisR J Laing, J Jakubowski, I H Kunkler, et al.
Pageof 19